ARK Investment Management - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 45 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$57,684,000
-41.2%
7,711,724
-14.7%
0.12%
-55.9%
Q4 2020$98,098,000
-1.0%
9,041,321
-19.4%
0.26%
-55.6%
Q3 2020$99,119,000
+9.2%
11,212,506
+31.7%
0.59%
-39.8%
Q2 2020$90,750,000
+159.4%
8,513,133
+44.3%
0.98%
+11.9%
Q1 2020$34,983,000
-0.3%
5,899,398
+16.2%
0.87%
-1.5%
Q4 2019$35,088,000
-11.8%
5,077,807
+32.4%
0.88%
+1.8%
Q3 2019$39,804,000
+13.4%
3,834,728
+1.1%
0.87%
-1.8%
Q2 2019$35,112,000
+28.4%
3,791,756
+26.7%
0.88%
+13.3%
Q1 2019$27,353,000
+99.6%
2,992,700
+21.6%
0.78%
+40.2%
Q4 2018$13,706,000
-48.2%
2,460,621
+10.7%
0.56%
-30.4%
Q3 2018$26,462,000
+44.0%
2,221,870
+23.5%
0.80%
+18.9%
Q2 2018$18,373,000
-5.9%
1,799,553
+19.6%
0.67%
-30.6%
Q1 2018$19,533,000
+140.5%
1,504,890
+80.3%
0.97%
+49.9%
Q4 2017$8,122,000
+2749.8%
834,757
+4614.8%
0.65%
+1076.4%
Q2 2017$285,000
+117.6%
17,705
+114.7%
0.06%
+44.7%
Q1 2017$131,000
+211.9%
8,245
+137.5%
0.04%
+153.3%
Q4 2016$42,0003,4710.02%
Other shareholders

There were no reported owners of SYROS PHARMACEUTICALS INC in Q1 2017.

NameSharesValueWeighting ↓
View complete list of SYROS PHARMACEUTICALS INC shareholders